Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15397 total
TTD enters the back half of May having absorbed one of its worst post-earnings weeks in recent memory — down 14% on the week to $21.14, with a broad analyst target-cutting exercise following a Q1 miss that confirmed…
CRISPR Therapeutics enters mid-May with one of the most heavily shorted profiles in the gene-editing space — yet the lending market has loosened meaningfully from its April extremes, creating a tension at the heart of…
Bionano Genomics heads into the post-earnings session with a story that is harder to dismiss than its micro-cap price suggests — but short sellers have yet to be convinced. The company reported Q1 2026 earnings after…
Outlook Therapeutics heads into its fiscal Q2 earnings release tomorrow — May 14 — with short sellers having tripled their position in six weeks and the options market tilting heavily toward calls. Short interest has…
Insight Molecular Diagnostics heads into the aftermath of its Q1 earnings print with a rare convergence: short interest more than doubling in a month, options tilting to the most defensive reading in a year, and a…
QMOM, the Alpha Architect U.S. Quantitative Momentum ETF, heads into mid-May with a striking divergence: short interest nearly doubled over the past month while the borrow market remains exceptionally loose. The most…
Madison Square Garden Sports Corp. heads into this week with a quietly building short position and a freshly downgraded Citi rating — a pairing that deserves attention even as the stock holds near its year-to-date…
Presurance Holdings is a micro-cap insurance name that just dropped fresh quarterly numbers — and the setup heading into the week tells two competing stories at once. Q1 adjusted EPS came in at -$0.16, a meaningful…
vTv Therapeutics just reported Q1 2026 results that blew past every estimate on the Street, landing EPS of $1.65 against a consensus of -$0.10 and revenue of $36.8M against a $20M forecast — and the timing couldn't be…
Shopify enters the week after a bruising earnings reaction with short sellers rebuilding positions and the options market sending a contrarian signal — the two rarely point in opposite directions this clearly. The Q1…
Fluent, Inc. reported Q1 2026 results after the close on May 13 — a beat on adjusted EPS but a miss on revenue — arriving into a week where the stock had already shed 11.5% and short interest was quietly…
Restaurant Brands International heads into a critical stretch with short sellers having nearly doubled their position over six weeks — and a Popeyes brand under pressure just weeks before the next earnings date. Short…
Nomad Foods heads into the post-earnings week with one clear tension: the stock fell sharply after its Q1 print, yet short sellers are cutting exposure at the fastest pace in months. The earnings reaction was brutal.…
HubSpot enters the week after earnings as a stock in freefall — and its own founders are stepping in to buy. The Q1 print on May 7 triggered a 16% single-day collapse. The stock shed another 6% Tuesday. It now trades…
Energous Corporation enters the post-earnings session with short sellers adding pressure into a revenue miss — the stock down 5.5% on the week despite a partial EPS beat today. The earnings story is the sharpest angle…
AIRR — the First Trust RBA American Industrial Renaissance ETF — enters mid-May with a short-interest spike that looks more tactical than structural, sitting against a backdrop of improving one-month price…
RLMD dropped its Q1 results on May 12 and filed a mixed-shelf offering the same evening — two developments that together define the stock's near-term tension: a credible clinical story advancing toward a mid-2026 Phase…
IceCure Medical enters its post-earnings week under dual pressure: a Q1 revenue miss and a fresh Nasdaq compliance notice have coincided with the sharpest short-selling build the stock has seen in months. The catalyst…
Intercontinental Exchange heads into its Q1 2026 results on Thursday with short sellers rebuilding positions and options traders edging more cautious — a mild but notable shift for a stock that bears rarely bother…
MacroGenics enters the back half of May with fresh earnings momentum — Q1 results just crossed the wire, and shorts who built positions over the past month are now sitting on a 19% one-day jump. The earnings print…
